MYLAN INC., as Issuer, MYLAN N.V. as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of December 21, 2012First Supplemental Indenture • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • New York
First Supplemental Indenture (this “Supplemental Indenture”), dated as of February 27, 2015, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Mylan Inc., a Pennsylvania corporation (the “Company”), and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
MYLAN INC., as Issuer, MYLAN N.V. as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee SECOND SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of NOVEMBER 29, 2013Second Supplemental Indenture • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • New York
Second Supplemental Indenture (this “Supplemental Indenture”), dated as of February 27, 2015, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Mylan Inc., a Pennsylvania corporation (the “Company”), and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
SHAREHOLDER AGREEMENTShareholder Agreement • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • New York
This Shareholder Agreement (this “Agreement”) is dated and effective as of February 27, 2015 between and among Mylan N.V., a public limited liability corporation (naamloze vennootschap) organized under the Laws of the Netherlands (“New Mylan”), Abbott Laboratories, an Illinois corporation (“Abbott”), Laboratoires Fournier S.A.S., a simplified corporation (Société par actions simplifiée) organized under the Laws of France (“Abbott France”), Abbott Established Products Holdings (Gibraltar) Limited, a private company limited by shares organized under the Laws of Gibraltar (“Abbott Gibraltar”), and Abbott Investments Luxembourg S.à r.l., a Luxembourg private limited company (Société à responsabilité limitée) organized under the Laws of Luxembourg (“Abbott Luxembourg,” and together with Abbott, Abbott France and Abbott Gibraltar and each of their respective Permitted Transferees (as defined below), the “Abbott Shareholders”). New Mylan and the Abbott Shareholders are referred to in this Agr
MYLAN INC., as Issuer, MYLAN N.V. as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee THIRD SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of SEPTEMBER 15, 2008Third Supplemental Indenture • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • New York
Third Supplemental Indenture (this “Supplemental Indenture”), dated as of February 27, 2015, among Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands (the “Guarantor”), Mylan Inc., a Pennsylvania corporation (the “Company”), and The Bank of New York Mellon, as trustee under the Indenture referred to below (the “Trustee”).
MYLAN INC., as Issuer, MYLAN N.V. and THE BANK OF NEW YORK MELLON, as Trustee SECOND SUPPLEMENTAL INDENTURE DATED as of FEBRUARY 27, 2015 TO THE INDENTURE DATED as of SEPTEMBER 15, 2008,Second Supplemental Indenture • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • New York
SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of February 27, 2015, among Mylan Inc., a Pennsylvania corporation (the “Company”), Mylan N.V., a public limited liability company (naamloze vennootschap) organized and existing under the laws of the Netherlands and formerly known as New Moon B.V. (“Parent”), and The Bank of New York Mellon, as trustee under the Indenture referred to herein (the “Trustee”).
MYLAN N.V. INDEMNIFICATION AGREEMENTIndemnification Agreement • February 27th, 2015 • Mylan B.V. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (the “Agreement”) is made this day of , 2015, by and between Mylan N.V., a public limited company (naamloze vennootschap) organized in the Netherlands (the “Company”), and (“Indemnitee”).
